Gary Woodnutt

2.5k total citations
45 papers, 1.9k citations indexed

About

Gary Woodnutt is a scholar working on Pharmacology, Molecular Biology and Molecular Medicine. According to data from OpenAlex, Gary Woodnutt has authored 45 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 15 papers in Molecular Biology and 13 papers in Molecular Medicine. Recurrent topics in Gary Woodnutt's work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Antibiotic Resistance in Bacteria (13 papers) and Pneumonia and Respiratory Infections (6 papers). Gary Woodnutt is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (17 papers), Antibiotic Resistance in Bacteria (13 papers) and Pneumonia and Respiratory Infections (6 papers). Gary Woodnutt collaborates with scholars based in United States, United Kingdom and Austria. Gary Woodnutt's co-authors include Rodney W. Lappe, Hanhua Huang, Abhijit Bhat, Valerie Berry, Yinduo Ji, Martin Rosenberg, Martin Burnham, Patrick V. Warren, Andrea Marra and L Mizen and has published in prestigious journals such as Science, Journal of Clinical Oncology and Nature reviews. Cancer.

In The Last Decade

Gary Woodnutt

45 papers receiving 1.8k citations

Peers

Gary Woodnutt

PHARM

EPIDE

GENET

Sherin S. Abdel‐Meguid United States

Nina M. Haste United States

Sébastien Guiral Canada

Yuzuru Akamatsu Japan

Nicola G. Wallis United Kingdom

Joyce Mordenti United States

Malika Kumarasiri United States

Tapan Biswas United States

Christophe Briand Switzerland

Isabelle Broutin France

Sherin S. Abdel‐Meguid United States

Gary Woodnutt

1.2k ×1.2

191 ×0.7

PHARM

307 ×1.3

EPIDE

384 ×1.6

129 ×0.6

GENET

Citations per year, relative to Gary Woodnutt Gary Woodnutt (= 1×) peers Sherin S. Abdel‐Meguid

Countries citing papers authored by Gary Woodnutt

Since Specialization

Citations

This map shows the geographic impact of Gary Woodnutt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Woodnutt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Woodnutt more than expected).

Fields of papers citing papers by Gary Woodnutt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Woodnutt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Woodnutt. The network helps show where Gary Woodnutt may publish in the future.

Co-authorship network of co-authors of Gary Woodnutt

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Woodnutt. A scholar is included among the top collaborators of Gary Woodnutt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Woodnutt. Gary Woodnutt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Swift, Steven M., Xavier Vila‐Farrés, Wessam Abdelhady, et al.. (2024). The Engineered Lysin CF-370 Is Active Against Antibiotic-Resistant Gram-Negative Pathogens In Vitro and Synergizes With Meropenem in Experimental Pseudomonas aeruginosa Pneumonia. The Journal of Infectious Diseases. 230(2). 309–318. 3 indexed citations

Huang, Jie, Tetsuya Ishino, Gang Chen, et al.. (2013). Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody. Journal of Pharmacology and Experimental Therapeutics. 346(2). 270–280. 102 indexed citations

Tong, Huimin, Lei Zhang, Allan Kaspar, et al.. (2013). Peptide-Conjugation Induced Conformational Changes in Human IgG1 Observed by Optimized Negative-Staining and Individual-Particle Electron Tomography. Scientific Reports. 3(1). 1089–1089. 29 indexed citations

Huang, Hanhua, Dingguo Liu, Lingna Li, et al.. (2011). Specifically Targeting Angiopoietin-2 Inhibits Angiogenesis, Tie2-Expressing Monocyte Infiltration, and Tumor Growth. Clinical Cancer Research. 17(5). 1001–1011. 121 indexed citations

Li, Lingna, Hanhua Huang, Venkata Ramana Doppalapudi, et al.. (2011). Antitumor Efficacy of a Thrombospondin 1 Mimetic CovX-Body. Translational Oncology. 4(4). 249–257. 18 indexed citations

Demarest, Stephen J., Mangala J. Hariharan, Jared Salbato, et al.. (2010). Neutralization ofClostridium difficiletoxin A using antibody combinations. mAbs. 2(2). 190–198. 28 indexed citations

Schoepp, Randal J., Oliver Schröder, Trevin Holland, et al.. (2008). Rapid discovery and optimization of therapeutic antibodies against emerging infectious diseases. Protein Engineering Design and Selection. 21(8). 495–505. 7 indexed citations

Woodnutt, Gary, Bernard N. Violand, & Michael North. (2008). Advances in protein therapeutics.. PubMed. 11(6). 754–61. 14 indexed citations

Demarest, Stephen J., Jared Salbato, Jingping Zhong, et al.. (2005). Structural Characterization of the Cell Wall Binding Domains of Clostridium difficile Toxins A and B; Evidence that Ca2+ Plays a Role in Toxin A Cell Surface Association. Journal of Molecular Biology. 346(5). 1197–1206. 16 indexed citations

10.

Berry, Valerie, et al.. (2005). Comparative Bacteriological Efficacy of Pharmacokinetically Enhanced Amoxicillin-Clavulanate against Streptococcus pneumoniae with Elevated Amoxicillin MICs and Haemophilus influenzae. Antimicrobial Agents and Chemotherapy. 49(3). 908–915. 9 indexed citations

11.

Zengler, Karsten, Marion Walcher, Gerardo Toledo, et al.. (2005). High‐Throughput Cultivation of Microorganisms Using Microcapsules. Methods in enzymology on CD-ROM/Methods in enzymology. 397. 124–130. 60 indexed citations

12.

Ji, Yinduo, Gary Woodnutt, Martin Rosenberg, & Martin Burnham. (2002). Identification of essential genes in Staphylococcus aureus using inducible antisense RNA. Methods in enzymology on CD-ROM/Methods in enzymology. 358. 123–128. 20 indexed citations

13.

Braga, Pier Carlo, M. Dal Sasso, & Gary Woodnutt. (2002). Staphylococcus aureusandEscherichia coliAdhesion to Human Cells Is Reduced by Sub-MICs of Gemifloxacin. Journal of Chemotherapy. 14(1). 41–46. 4 indexed citations

14.

Ji, Yinduo, et al.. (2001). Identification of Critical Staphylococcal Genes Using Conditional Phenotypes Generated by Antisense RNA. Science. 293(5538). 2266–2269. 328 indexed citations

15.

HANNAN, P. C. T. & Gary Woodnutt. (2000). In vitro activity of gemifloxacin (SB 265805; LB20304a) against human mycoplasmas. Journal of Antimicrobial Chemotherapy. 45(3). 367–369. 34 indexed citations

16.

Woodnutt, Gary, et al.. (1990). Penetration of amoxycillin, ticarcillin and clavulanic add into lymph after intravenous infusion in rabbits to simulate human serum pharmacokinetics. Journal of Antimicrobial Chemotherapy. 26(5). 695–704. 2 indexed citations

17.

Everett, Jeremy R., John W. Tyler, & Gary Woodnutt. (1989). A study of flucloxacillin metabolites in rat urine by two-dimensional 1H, 19F COSY NMR. Journal of Pharmaceutical and Biomedical Analysis. 7(3). 397–403. 9 indexed citations

18.

Woodnutt, Gary, et al.. (1988). Temocillin efficacy in experimental Klebsiella pneumoniae meningitis after infusion into rabbit plasma to simulate antibiotic concentrations in human serum. Antimicrobial Agents and Chemotherapy. 32(11). 1705–1709. 11 indexed citations

19.

Mizen, L & Gary Woodnutt. (1988). A critique of pharmacokinetics. Journal of Antimicrobial Chemotherapy. 21(3). 273–278. 12 indexed citations

20.

Woodnutt, Gary & D. S. Parker. (1978). Rabbit liver acetyl-CoA synthetase. Biochemical Journal. 175(2). 757–759. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact